https://www.medicalnewstoday.com/amp/articles/blood-biomarker-may-predict-mortality-in-covid-19-patients
"The researchers initially measured three main biomarkers in the blood of the participants: inflammatory proteins, vRNA, and the level of SARS-CoV-2 antibodies.
They found that the amount of vRNA [from any source] in a patient’s blood provided the best predictor of mortality risk — noncritical patients had less vRNA than critical patients. Also, those who died had high levels of vRNA in their blood, compared with participants who survived.
Importantly, the researchers reported that the other biomarkers did not help predict mortality rates."
So the level of he level of SARS-CoV-2 antibodies had NO influence on patient outcomes, and since the vaccine contributes to vRNA load the vaccine only increases patent mortality without any benefit.
"The researchers initially measured three main biomarkers in the blood of the participants: inflammatory proteins, vRNA, and the level of SARS-CoV-2 antibodies.
They found that the amount of vRNA [from any source] in a patient’s blood provided the best predictor of mortality risk — noncritical patients had less vRNA than critical patients. Also, those who died had high levels of vRNA in their blood, compared with participants who survived.
Importantly, the researchers reported that the other biomarkers did not help predict mortality rates."
So the level of he level of SARS-CoV-2 antibodies had NO influence on patient outcomes, and since the vaccine contributes to vRNA load the vaccine only increases patent mortality without any benefit.
